lifestyle.side.cr

Author: AC Immune SA

AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM

May 12, 2026
AC Immune First Quarter 2026 Financial and Corporate Updates

April 30, 2026
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer’s Disease

April 30, 2026
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly

April 7, 2026
AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026

March 19, 2026
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update

March 13, 2026
AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026

March 5, 2026
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor

February 24, 2026